文献速递前列腺癌

68Ga-PSMA正电子发射断层扫描与多参数MRI能否指导根治性前列腺切除术后生化复发的治疗

Can 68 Ga-PSMA positron emission tomography and multiparametric MRI guide treatment for biochemical recurrence after radical prostatectomy?
PubMed 文献 · BJU Int · 2023-05-16

本研究评估多参数MRI(mpMRI)与68Ga-PSMA PET/CT在根治性前列腺切除术后生化复发(PSA>0.2 ng/mL)患者抢救治疗决策中的作用。117例患者接受配对扫描,53.0%(62/117)初查发现可检出病灶、47.0%(55/117)未检出;45.3%(53/117)因影像无病灶或存在远处病灶而免于早期抢救性放疗。作者认为影像可指导抢救治疗的时机与必要性,但需更大规模或随机试验验证。

要点

  • 117例生化复发患者行配对mpMRI与68Ga-PSMA PET/CT,53.0%(62/117)初查可检出病灶。
  • 影像阴性者中47/55观察,其中53.2%因PSA升高复查,31.9%(15/47)免于抢救性放疗。
  • 45.3%(53/117)因影像无病灶或远处病灶免于早期抢救性放疗,延迟放疗者PSA反应仍良好。

核心结论

  • 作者认为mpMRI与68Ga-PSMA PET/CT可指导抢救治疗的时机与必要性,并可能减少不必要的抢救性放疗相关并发症。
  • 作者指出需要更大规模或随机试验来验证上述结论。

研究设计与样本

  • 本研究为观察性设计,纳入117例根治性前列腺切除术后生化复发(PSA>0.2 ng/mL)患者,行配对mpMRI与68Ga-PSMA PET/CT扫描。
  • 对患者、肿瘤、PSA及影像特征采用描述性统计进行分析。

主要发现

  • 117例中53.0%(62/117)初查可检出病灶,47.0%(55/117)未检出病灶。
  • 影像未检出病灶的55例中,8/55接受即刻抢救性放疗,47/55接受观察。
  • 初始观察的影像阴性患者中,46.8%(22/47)未达到复查影像阈值,53.2%因PSA升高重新扫描。
  • 重新扫描患者中31.9%(15/47)因证实远处病灶或复查影像无病灶而免于抢救性放疗。
  • 117例中45.3%(53)因影像无病灶或存在远处病灶免于早期抢救性放疗;接受延迟抢救性放疗者仍维持良好PSA反应;影像阴性但具高危特征仍接受抢救性放疗者PSA反应满意。

临床怎么用

  • 作者认为mpMRI与68Ga-PSMA PET/CT可用于指导抢救治疗的时机与必要性,使治疗依据检出的病灶个体化。
  • 作者认为该策略可能减少不必要的抢救性放疗相关并发症。
  • 作者指出需要更大规模或随机试验验证。

局限性

  • 研究局限包括观察性设计。
  • 缺乏病因特异性或总生存数据。
  • 需要更大规模或随机试验验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the role of multiparametric magnetic resonance imaging (mpMRI) and Gallium-68 (68 Ga)-prostate-specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT) in guiding salvage therapy for patients with biochemical recurrence (BCR) post-radical prostatectomy. PATIENTS AND METHODS: Patients were evaluated with paired mpMRI and 68 Ga-PSMA PET/CT scans for BCR (prostate-specific antigen [PSA] >0.2 ng/mL). Patient, tumour, PSA and imaging characteristics were analysed with descriptive statistics. RESULTS: A total of 117 patients underwent paired scans to investigate BCR, of whom 53.0% (62/117) had detectable lesions on initial scans and 47.0% (55/117) did not. Of those without detectable lesions, 8/55 patients proceeded to immediate salvage radiotherapy (sRT) and 47/55 were observed. Of patients with negative imaging who were initially observed, 46.8% (22/47) did not reach threshold for repeat imaging, while 53.2% were rescanned due to rising PSA levels. Of these rescanned patients, 31.9% (15/47) were spared sRT due to proven distant disease, or due to absence of disease on repeat imaging. Of the original 117 patients, 53 (45.3%) were spared early sRT due to absence of disease on imaging or presence of distant disease, while those undergoing delayed sRT still maintained good PSA responses. Of note, patients with high-risk features who underwent sRT despite negative imaging demonstrated satisfactory PSA responses to sRT. Study limitations include the observational design and absence of cause-specific or overall survival data. CONCLUSION: Our findings support the use of mpMRI and 68 Ga-PSMA PET/CT in guiding timing and necessity of salvage therapy tailored to detected lesions, with potential to reduce unnecessary sRT-related morbidity. Larger or randomized trials are warranted to validate this.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Khanna Y, Chinni V, Gnanasambantham K, et al. Can 68 Ga-PSMA positron emission tomography and multiparametric MRI guide treatment for biochemical recurrence after radical prostatectomy? BJU Int. 2023. PMID: 37190993. doi:10.1111/bju.16037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。